Clinical Research Directory
Browse clinical research sites, groups, and studies.
Lactoferrin Use in ICU Patients
Sponsor: Mansoura University Hospital
Summary
Introduction: Lactoferrin has several uses due to its effects. It has anti-inflammatory, antioxidant, immunomodulatory, antibacterial, antifungal, and antiviral effects. Its safety is proven by food and drug administration. Aims: The objective is to study the effect of lactoferrin on improving clinical outcomes in ICU patients, and also to evaluate its safety. Patients and populations: A sample of 660 patients (330 patients in both groups A, and B) who will be admitted to ICU departments in Mansoura university hospital will be used to represent the population in ICU. Methods: A sample of 660 participants was randomized 1:1 into two groups (group A (330 patients), and group B (330 patients)). This study is a single blind, randomized controlled clinical trial. Randomization was performed by independent clinical pharmacists working in hospital ICU departments.
Official title: The Effect of Lactoferrin in Improving Clinical Outcomes in ICU Patients
Key Details
Gender
All
Age Range
Any - Any
Study Type
INTERVENTIONAL
Enrollment
660
Start Date
2025-12-29
Completion Date
2027-12-29
Last Updated
2025-07-28
Healthy Volunteers
Yes
Conditions
Interventions
Lactoferrin
antioxidant, immunomodulatory, anti-inflammatory, antimicrobial effect
Antioxidant therapies
Acetyl cysteine 600 mg / 12 hr
Dexamethasone
dexamethasone I.V 8 mg / day
Antibacterial therapies
Antibacterial drugs in their approved doses
Locations (1)
Mansoura University hospital
Al Mansurah, El-dakhlia, Egypt